Cédric Leroy

1.3k total citations
20 papers, 871 citations indexed

About

Cédric Leroy is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Cédric Leroy has authored 20 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Hematology. Recurrent topics in Cédric Leroy's work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Cédric Leroy is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Cédric Leroy collaborates with scholars based in France, Switzerland and United States. Cédric Leroy's co-authors include Serge Roche, Valérie Simon, Audrey Sirvent, Mohamed Bentires‐Alj, Gabriel Étienne, François‐Xavier Mahon, Valérie Lagarde, Jean‐Max Pasquet, Débora Bonenfant and Bruno Robert and has published in prestigious journals such as Nature Communications, Blood and Cancer Research.

In The Last Decade

Cédric Leroy

19 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cédric Leroy France	13	524	255	192	143	107	20	871
Trevor Price United States	9	340 0.6×	308 1.2×	167 0.9×	86 0.6×	140 1.3×	21	849
Jieyi Wang United States	15	443 0.8×	291 1.1×	127 0.7×	70 0.5×	55 0.5×	29	851
Tadaaki Kishi Canada	15	295 0.6×	187 0.7×	204 1.1×	405 2.8×	53 0.5×	17	741
Niranjan Yanamandra United States	18	441 0.8×	265 1.0×	155 0.8×	76 0.5×	122 1.1×	28	823
John Gooya United States	16	448 0.9×	237 0.9×	197 1.0×	65 0.5×	204 1.9×	25	779
Yoko Ueno Japan	13	901 1.7×	377 1.5×	268 1.4×	162 1.1×	125 1.2×	19	1.4k
Kristina West United States	9	646 1.2×	187 0.7×	98 0.5×	87 0.6×	69 0.6×	12	819
Frank J.G. Scherpen Netherlands	14	363 0.7×	146 0.6×	149 0.8×	103 0.7×	89 0.8×	33	592
Joan MacNeill United States	6	841 1.6×	303 1.2×	111 0.6×	61 0.4×	63 0.6×	6	1.1k
Jon S. Zawistowski United States	17	603 1.2×	206 0.8×	77 0.4×	77 0.5×	35 0.3×	28	1.5k

Countries citing papers authored by Cédric Leroy

Since Specialization

Citations

This map shows the geographic impact of Cédric Leroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Leroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Leroy more than expected).

Fields of papers citing papers by Cédric Leroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cédric Leroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Leroy. The network helps show where Cédric Leroy may publish in the future.

Co-authorship network of co-authors of Cédric Leroy

This figure shows the co-authorship network connecting the top 25 collaborators of Cédric Leroy. A scholar is included among the top collaborators of Cédric Leroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cédric Leroy. Cédric Leroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leroy, Cédric, et al.. (2019). Performance simulation of different toolpaths in 2D1/2 pocket milling. AIP conference proceedings. 2113. 80001–80001. 1 indexed citations

Jeitany, Maya, Cédric Leroy, M. Lafitte, et al.. (2018). Inhibition of DDR 1‐ BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. EMBO Molecular Medicine. 10(4). 90 indexed citations

Leroy, Cédric, Pedro Marques Ramos, Karen Cornille, et al.. (2016). Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition. Breast Cancer Research. 18(1). 41–41. 60 indexed citations

Leroy, Cédric, Qiong Shen, Ronald A. Meyer, et al.. (2015). CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases. Oncogene. 34(44). 5593–5598. 26 indexed citations

Dubois, Fanny, Cédric Leroy, Valérie Simon, Christine Bénistant, & Serge Roche. (2015). YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells.. PubMed. 5(6). 1972–87. 19 indexed citations

Naudin, Cécile, Audrey Sirvent, Cédric Leroy, et al.. (2014). SLAP displays tumour suppressor functions in colorectal cancer via destabilization of the SRC substrate EPHA2. Nature Communications. 5(1). 3159–3159. 38 indexed citations

Sausgruber, Nina, Marie‐May Coissieux, Adrian Britschgi, et al.. (2014). Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases. Oncogene. 34(17). 2272–2278. 54 indexed citations

Leroy, Cédric, et al.. (2014). Anticipating mechanisms of resistance to PI3K inhibition in breast cancer: a challenge in the era of precision medicine. Biochemical Society Transactions. 42(4). 733–741. 9 indexed citations

Meyer, Dominique S., Shany Koren, Cédric Leroy, et al.. (2013). Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R. Oncogenesis. 2(9). e74–e74. 45 indexed citations

10.

Leroy, Cédric, Valérie Simon, Bruno Robert, et al.. (2013). Abstract 2085: The antileukemic drug nilotinib inhibits the invasive activity and the metastatic potential of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1.. Cancer Research. 73(8_Supplement). 2085–2085. 1 indexed citations

11.

Gioia, Romain, Cédric Leroy, Claire Drullion, et al.. (2011). Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells. Blood. 118(8). 2211–2221. 75 indexed citations

12.

Leroy, Cédric, Bruno Robert, Valérie Simon, & Serge Roche. (2010). 442 The Abl tyrosine kinase inhibitor Nilotinib inhibits invasive properties of colon cancer cells by targeting the discoidin domain receptor 1. European Journal of Cancer Supplements. 8(5). 113–113. 2 indexed citations

13.

Leroy, Cédric, Audrey Sirvent, Valérie Simon, et al.. (2009). Quantitative Phosphoproteomics Reveals a Cluster of Tyrosine Kinases That Mediates Src Invasive Activity in Advanced Colon Carcinoma Cells. Cancer Research. 69(6). 2279–2286. 93 indexed citations

14.

Pasquet, Jean‐Max, Romain Gioia, Claire Drullion, et al.. (2009). Tyrosine Kinase Proteins profiling of Nilotinib Resistant Chronic Myelogenous Leukemia Cells Unravels a Tyrosine Kinase-Mediated Bypass.. Blood. 114(22). 2175–2175. 1 indexed citations

15.

Mahon, François‐Xavier, Sandrine Hayette, Valérie Lagarde, et al.. (2008). Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression. Cancer Research. 68(23). 9809–9816. 174 indexed citations

16.

Sirvent, Audrey, Cédric Leroy, Anthony Boureux, Valérie Simon, & Serge Roche. (2008). The Src-like adaptor protein regulates PDGF-induced actin dorsal ruffles in a c-Cbl-dependent manner. Oncogene. 27(24). 3494–3500. 19 indexed citations

17.

Hayette, Sandrine, Valérie Lagarde, Franck E. Nicolini, et al.. (2008). Lyn Kinase Overexpression Is One of the Mechanisms of Resistance to Nilotinib In Chronic Myeloid Leukemia. Blood. 112(11). 3181–3181. 2 indexed citations

18.

Sirvent, Audrey, Anthony Boureux, Valérie Simon, Cédric Leroy, & Serge Roche. (2007). The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells. Oncogene. 26(52). 7313–7323. 52 indexed citations

19.

Trinquet, Eric, Michel Fink, Hervé Bazin, et al.. (2006). d-myo-Inositol 1-phosphate as a surrogate of d-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation. Analytical Biochemistry. 358(1). 126–135. 101 indexed citations

20.

Janel, Nathalie, Cédric Leroy, Florence Toti, et al.. (1999). Assessment of the Expression of Candidate Human Plasma Membrane Phospholipid Scramblase in Scott Syndrome Cells. Thrombosis and Haemostasis. 81(2). 322–323. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact